LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, announced it has won a Silver Bell Ringer Award in the Investor/Financial Relations Campaign category from the Publicity Club of New England for the agency’s work on behalf of its client, Ampio Pharmaceuticals, a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.
LaVoieHealthScience developed an Investor/Financial Relations strategic communications campaign to ensure on-message visibility for Ampio’s announcement of pivotal data for Ampion™ for the treatment of osteoarthritis of the knee.
The campaign included a press release that was offered to reporters on an embargoed basis, as well as a post-distribution follow-on campaign that targeted the full range of national, local, business, trade and orthopedic outlets. In addition to the earned media, the campaign included sponsored print and radio content. An important part of the campaign also included a full suite of “infrastructure” including detailed timelines and Q&A preparation.
“I want to thank our talented team and our client, Ampio for their specialized thinking and spot-on execution on this important investor communications program. We are honored to be recognized again in 2018 by the Publicity Club of New England,” stated Donna L. LaVoie, President and CEO.